UMB Bank’s Immunocore IMCR Stock Holding History

UMB Bank’s Portfolio IMCR Stock Details IMCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-17	Closed	-$590	–	2323
2025 Q4	$590	Hold	17	–	–	﹤0.01%	2240
2025 Q3	$618	Buy	+17	New	+$578	﹤0.01%	2117

Other funds holding IMCR

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

UMB Bank's IMCR Position: Q1 2026 in Review

UMB Bank sold out of Immunocore (IMCR) in Q1 2026, closing a stake of 17 shares — an estimated $590 sold.

UMB Bank first reported a position in IMCR in Q3 2025 and held it in 2 quarters. The position peaked at $618 in Q3 2025. 142 funds tracked by Wall St. Rank hold IMCR as of Q1 2026.

UMB Bank reported no remaining Immunocore position as of Q1 2026 after selling out during the quarter.
UMB Bank sold 17 Immunocore shares in Q1 2026, an estimated $590.
UMB Bank first reported a position in Immunocore in Q3 2025 and held it in 2 quarters.
UMB Bank's Immunocore position peaked at $618 in Q3 2025.
142 funds tracked by Wall St. Rank held Immunocore as of Q1 2026.

Based on UMB Bank's 13F filing for Q1 2026, filed 11 May 2026.